Results 141 to 150 of about 26,648 (276)

Facial Nerve Paralysis after General Anesthesia: A case report [PDF]

open access: bronze, 1998
Young Jung Yoon   +4 more
openalex   +1 more source

Equine trypanosomiasis, a systematic review and meta‐analyses: Prevalence, morbidity and mortality

open access: yesEquine Veterinary Journal, EarlyView.
Abstract Background Equine trypanosomiasis is a neglected protozoal disease. Objectives To perform a systematic search of literature to explore: (1) In equines what is the global geographical distribution and prevalence of trypanosomiasis? In low and middle‐income countries (LMICs) is trypanosomiasis more prevalent than in higher‐income countries (HICs)
Alexandra G. Raftery   +5 more
wiley   +1 more source

Facial Nerve in Foetal Cadavers: An Anatomical Study with Clinical Relevance

open access: yesOnline Journal of Health & Allied Sciences, 2016
Introduction: Facial nerve paralysis is a major complication of parotid surgery and is widely reported. Little attention is paid to the facial nerve trunk in children.
Kotian SR   +5 more
doaj  

Reversible facial nerve paralysis in a cat suspected to be associated with systemic hypertension. [PDF]

open access: yesJFMS Open Rep, 2021
Moretto L   +5 more
europepmc   +1 more source

Mycoplasma Hominis: A Rare Case of Acute Otitis Media and Facial Nerve Paralysis

open access: gold, 2022
Birkaran Sadhar   +3 more
openalex   +1 more source

Pan‐Europe Revisited: Inter‐War Debates and the EU's Pursuit of Geopolitical Power

open access: yesJCMS: Journal of Common Market Studies, EarlyView.
ABSTRACT The European Union's (EU) transformation from a peace project to an assertive geopolitical actor reflects enduring tensions in integration theory dating back to the inter‐war period. This paper develops a comparative framework distinguishing territorial integration logic, which emphasises bounded political communities and collective defence ...
Kamil Zwolski
wiley   +1 more source

Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open‐label extension study

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
This study evaluated long‐term safety and efficacy in patients with moderate‐to‐severe atopic dermatitis. Patients with and without previous nemolizumab experience received nemolizumab 30 mg Q4W plus TCS/TCI. Nemolizumab was well‐tolerated through 104 weeks with clinically meaningful improvements in disease signs and symptoms.
Matthias Augustin   +24 more
wiley   +1 more source

Bilateral facial nerve paralysis and acute HIV-1 infection [PDF]

open access: diamond, 2011
Roman Leonid Kleynberg   +1 more
openalex   +1 more source

Home - About - Disclaimer - Privacy